Tobias Welponer

9PUBLICATIONS
26CO-AUTHORS
Major global burdens of diseaseCancer geneticsChemotherapyEpidemiological modellingMedical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 09, 2026
AI-Based Segmentation of Wound Types Caused by Epidermolysis Bullosa.

|Oct 10, 2025
Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measure.

Eva W H Korte, Peter C van den Akker, Dimitra Kiritsi

|Jul 28, 2024
Systematic review on antipruritic therapies for patients with Epidermolysis bullosa.

Tobias Welponer, Christian Puttinger, Eva W H Korte

|Sep 05, 2023
Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.

T Welponer, D D Weber, L Trattner

|May 21, 2023
Nivolumab for locally advanced and metastatic cutaneous squamous cell carcinoma (NIVOSQUACS study)-Phase II data covering impact of concomitant haematological malignancies.

R Lang, T Welponer, E Richtig

|Apr 25, 2023
Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonization.

Eva W H Korte, Tobias Welponer, Jan Kottner

Pageof 2

Frequent Collaborators

5 joint publications

Marieke C Bolling

5 joint publications

Eva W H Korte

4 joint publications

Verena Wally

4 joint publications

Peter C van den Akker